Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:54 UTC |
---|
HMDB ID | HMDB0015205 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Atazanavir |
---|
Description | Atazanavir (formerly known as BMS-232632) is an antiretroviral drug of the protease inhibitor (PI) class. Like other antiretrovirals, it is used to treat infection of human immunodeficiency virus (HIV). Atazanavir is distinguished from other PIs in that it can be given once-daily (rather than requiring multiple doses per day) and has lesser effects on the patient's lipid profile (the amounts of cholesterol and other fatty substances in the blood). Like other protease inhibitors, it is used only in combination with other HIV medications. The U.S. Food and Drug Administration (FDA) approved atazanavir on June 20, 2003. [Wikipedia ] |
---|
Structure | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1 |
---|
Synonyms | Value | Source |
---|
Atazanavirum | ChEBI | ATZ | ChEBI | Latazanavir | ChEBI | Zrivada | ChEBI | Reyataz | Kegg | Atazanavir sulfate | HMDB | Atazanavir sulphate | HMDB | ATV | HMDB | BMS-232632 | HMDB | Sulfate, atazanavir | HMDB | 3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester | HMDB |
|
---|
Chemical Formula | C38H52N6O7 |
---|
Average Molecular Weight | 704.8555 |
---|
Monoisotopic Molecular Weight | 704.389748048 |
---|
IUPAC Name | methyl N-[(1S)-1-{[(2S,3S)-3-hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-N'-{[4-(pyridin-2-yl)phenyl]methyl}butanehydrazido]-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate |
---|
Traditional Name | atazanavir |
---|
CAS Registry Number | 198904-31-3 |
---|
SMILES | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C |
---|
InChI Identifier | InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1 |
---|
InChI Key | AXRYRYVKAWYZBR-GASGPIRDSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as valine and derivatives. Valine and derivatives are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Valine and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Valine or derivatives
- Alpha-amino acid amide
- 2-phenylpyridine
- Phenylbutylamine
- Amphetamine or derivatives
- Monocyclic benzene moiety
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Benzenoid
- Pyridine
- Methylcarbamate
- Heteroaromatic compound
- Carbamic acid ester
- Carboxamide group
- Carboxylic acid hydrazide
- Carbonic acid derivative
- Secondary carboxylic acid amide
- Secondary alcohol
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organic nitrogen compound
- Alcohol
- Carbonyl group
- Organooxygen compound
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0033 g/L | Not Available | LogP | 4.5 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Atazanavir,2TMS,isomer #1 | COC(=O)N[C@H](C(=O)NN(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O[Si](C)(C)C)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)C(C)(C)C | 4814.7 | Semi standard non polar | 33892256 | Atazanavir,2TMS,isomer #1 | COC(=O)N[C@H](C(=O)NN(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O[Si](C)(C)C)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)C(C)(C)C | 4367.1 | Standard non polar | 33892256 | Atazanavir,2TMS,isomer #1 | COC(=O)N[C@H](C(=O)NN(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O[Si](C)(C)C)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)C(C)(C)C | 6420.2 | Standard polar | 33892256 | Atazanavir,2TMS,isomer #10 | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)N(C(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 4793.2 | Semi standard non polar | 33892256 | Atazanavir,2TMS,isomer #10 | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)N(C(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 4528.6 | Standard non polar | 33892256 | Atazanavir,2TMS,isomer #10 | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)N(C(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 6514.0 | Standard polar | 33892256 | Atazanavir,2TMS,isomer #2 | COC(=O)N[C@H](C(=O)NN(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O[Si](C)(C)C)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](NC(=O)OC)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 4846.6 | Semi standard non polar | 33892256 | Atazanavir,2TMS,isomer #2 | COC(=O)N[C@H](C(=O)NN(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O[Si](C)(C)C)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](NC(=O)OC)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 4377.1 | Standard non polar | 33892256 | Atazanavir,2TMS,isomer #2 | COC(=O)N[C@H](C(=O)NN(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O[Si](C)(C)C)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](NC(=O)OC)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 6495.9 | Standard polar | 33892256 | Atazanavir,2TMS,isomer #3 | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC1=CC=C(C2=CC=CC=N2)C=C1)N(C(=O)[C@@H](NC(=O)OC)C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)C(C)(C)C | 4828.8 | Semi standard non polar | 33892256 | Atazanavir,2TMS,isomer #3 | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC1=CC=C(C2=CC=CC=N2)C=C1)N(C(=O)[C@@H](NC(=O)OC)C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)C(C)(C)C | 4457.1 | Standard non polar | 33892256 | Atazanavir,2TMS,isomer #3 | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC1=CC=C(C2=CC=CC=N2)C=C1)N(C(=O)[C@@H](NC(=O)OC)C(C)(C)C)[Si](C)(C)C)O[Si](C)(C)C)C(C)(C)C | 6534.5 | Standard polar | 33892256 | Atazanavir,2TMS,isomer #4 | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC1=CC=C(C2=CC=CC=N2)C=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)O[Si](C)(C)C)C(C)(C)C | 4803.3 | Semi standard non polar | 33892256 | Atazanavir,2TMS,isomer #4 | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC1=CC=C(C2=CC=CC=N2)C=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)O[Si](C)(C)C)C(C)(C)C | 4370.5 | Standard non polar | 33892256 | Atazanavir,2TMS,isomer #4 | COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC1=CC=C(C2=CC=CC=N2)C=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)O[Si](C)(C)C)C(C)(C)C | 6421.8 | Standard polar | 33892256 | Atazanavir,2TMS,isomer #5 | COC(=O)N([C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)C(C)(C)C)[Si](C)(C)C | 4788.9 | Semi standard non polar | 33892256 | Atazanavir,2TMS,isomer #5 | COC(=O)N([C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)C(C)(C)C)[Si](C)(C)C | 4444.8 | Standard non polar | 33892256 | Atazanavir,2TMS,isomer #5 | COC(=O)N([C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)C(C)(C)C)[Si](C)(C)C | 6398.5 | Standard polar | 33892256 | Atazanavir,2TMS,isomer #6 | COC(=O)N[C@H](C(=O)N(N(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 4791.2 | Semi standard non polar | 33892256 | Atazanavir,2TMS,isomer #6 | COC(=O)N[C@H](C(=O)N(N(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 4536.5 | Standard non polar | 33892256 | Atazanavir,2TMS,isomer #6 | COC(=O)N[C@H](C(=O)N(N(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 6506.5 | Standard polar | 33892256 | Atazanavir,2TMS,isomer #7 | COC(=O)N[C@H](C(=O)NN(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 4762.5 | Semi standard non polar | 33892256 | Atazanavir,2TMS,isomer #7 | COC(=O)N[C@H](C(=O)NN(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 4445.3 | Standard non polar | 33892256 | Atazanavir,2TMS,isomer #7 | COC(=O)N[C@H](C(=O)NN(CC1=CC=C(C2=CC=CC=N2)C=C1)C[C@H](O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 6476.1 | Standard polar | 33892256 | Atazanavir,2TMS,isomer #8 | COC(=O)N[C@H](C(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 4759.1 | Semi standard non polar | 33892256 | Atazanavir,2TMS,isomer #8 | COC(=O)N[C@H](C(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 4451.2 | Standard non polar | 33892256 | Atazanavir,2TMS,isomer #8 | COC(=O)N[C@H](C(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)NC(=O)[C@@H](N(C(=O)OC)[Si](C)(C)C)C(C)(C)C)[Si](C)(C)C)C(C)(C)C | 6463.2 | Standard polar | 33892256 | Atazanavir,2TMS,isomer #9 | COC(=O)N[C@H](C(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)N(C(=O)[C@@H](NC(=O)OC)C(C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C(C)(C)C | 4796.9 | Semi standard non polar | 33892256 | Atazanavir,2TMS,isomer #9 | COC(=O)N[C@H](C(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)N(C(=O)[C@@H](NC(=O)OC)C(C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C(C)(C)C | 4544.3 | Standard non polar | 33892256 | Atazanavir,2TMS,isomer #9 | COC(=O)N[C@H](C(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C2=CC=CC=N2)C=C1)N(C(=O)[C@@H](NC(=O)OC)C(C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C(C)(C)C | 6565.7 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (Non-derivatized) - 70eV, Positive | splash10-03xs-5617198000-83a5e695710baf354772 | 2017-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Atazanavir GC-MS (TBDMS_1_5) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 30V, Negative-QTOF | splash10-0a4i-0900000000-a688edc7c86f0564ba20 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 40V, Positive-QTOF | splash10-014r-0905010000-c909027e64ed0c6bc4d8 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 15V, Positive-QTOF | splash10-0a4i-0000000900-0bb22caf4b863566bd9c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 15V, Negative-QTOF | splash10-052r-0400109000-e7d7d8600202d4603b49 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 30V, Positive-QTOF | splash10-014i-0903000000-3b9b3a8adea9bb1eb957 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 50V, Positive-QTOF | splash10-014i-0901000000-53416755c850b58d778c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 30V, Positive-QTOF | splash10-052r-0309021800-ea619882f4fe2c00b481 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 10V, Positive-QTOF | splash10-0a4i-0000000900-12fe8f22e3abb6fcc9be | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 50V, Positive-QTOF | splash10-014i-0901000000-cebaefef46a60a79f326 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 20V, Positive-QTOF | splash10-0a4i-0000000900-2176c78cd40b45df512a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 20V, Positive-QTOF | splash10-0a4i-0000000900-bc7d9bee134e63ae6552 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 10V, Positive-QTOF | splash10-0a4i-0000000900-f123f82b3d344e90c694 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 30V, Positive-QTOF | splash10-052r-0309021800-9b965caf0be7610147e5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 40V, Positive-QTOF | splash10-014r-0905010000-b690776ff28fe5c6f7ae | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 50V, Negative-QTOF | splash10-0a4i-0900000000-2745c98fc68f31b0aaa1 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 10V, Negative-QTOF | splash10-0udi-0000000900-7e1de2ac8606722b93f7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 20V, Negative-QTOF | splash10-059i-0400009000-c82421a6236ad955ce10 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 40V, Negative-QTOF | splash10-0a4i-0900000000-54848dbe98136e86d7e2 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Atazanavir 30V, Negative-QTOF | splash10-0a4i-0900103000-7e2d2a1d46db762c8c86 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Atazanavir 10V, Positive-QTOF | splash10-053i-0201059200-b81c365212b43bb09c94 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Atazanavir 20V, Positive-QTOF | splash10-000x-1701398000-2f76a00f3c27929b553c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Atazanavir 40V, Positive-QTOF | splash10-0006-6903120000-8304658487ac35e7437b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Atazanavir 10V, Negative-QTOF | splash10-0kmu-1102009200-ca81976dd8359c5e3a13 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Atazanavir 20V, Negative-QTOF | splash10-0abl-1403129000-594995355b56a2f05946 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Atazanavir 40V, Negative-QTOF | splash10-0a4i-7903112000-64d9d4a7da4cc1e44326 | 2016-08-03 | Wishart Lab | View Spectrum |
|
---|